pharma The president of the Institut Pasteur talks about how they must build on their differentiating factors, with a focus on interdisciplinary research, why they are not a French institute with international partnerships, but an international institute that is based in France and how if there was one aspect he would…
pharma With almost thirty years of experience in the life sciences sector, local Dutch consultancy firm Baggerman Farma Consult offers a wide portfolio of services to its clients in the pharmaceutical and life sciences industry to meet all of their regulatory needs. Kees Baggerman, CEO and founder, highlights the new Gateway…
Pharma The president of HAS sheds light on the seemingly complex French healthcare system, explains HAS’ role within that context and provides an honest assessment of the system’s advantages and flaws. He also discusses the issues of maintaining the sustainability of the French healthcare budget and the importance of increasing European…
pharma Professor Paul Smits, Dean and Vice Chairman of Radboud University Medical Center in the Netherlands, shares his insights into the strengths of the country’s research climate and the challenges posed by the increasingly high cost of innovative drugs on the healthcare budget. Prof. Smits highlights the benefits that could be…
pharma As Director of the Netherlands’ association for innovative medicines, Gerard Schouw outlines new strategies to enhance the Dutch research climate; foster greater collaboration between all stakeholders and improve public perception of the industry. In light of the upcoming Dutch Presidency of the European Union, the Netherlands intends to lead the…
Pharma The president and founder of FSNB Health & Care, a healthcare consultancy, discusses his motivations behind the creation of his company, as well as the challenges and opportunities the pharmaceutical industry in France faces, in the context of his extensive industry experience. After a long and distinguished career in many…
pharma Rikus Wolbers, Director at Novio Tech Campus, a key international incubator for R&D and manufacturing companies who are active at the interface of life sciences and high tech, and John Schalken, Program Director SMB Life Sciences, give an overview of the impressive developments in the Nijmegen area and the potential…
Pharma Bayer broke into the top ten multinationals in Egypt this year, after achieving a remarkable 110 percent growth over the last two years. General manager Hatem Safei discusses the developments that drove this strong expansion, and the overall potential he sees in the healthcare market going forward. What are the…
Pharma The President of CEPS, the French pricing agency, reveals the issues around the launch of the hepatitis C drug Sovaldi in 2014 and of CEPS´ role to ensure that innovative products are available to all patients who are in need of them. The Sovaldi case has focused public attention on the pricing of drugs in…
Pharma “Egypt will become the largest market for pharmaceuticals within the region in the next three years”; Ahsraf Elkhouly, Executive Director the Egyptian Society for Pharmaceutical Research (ESPR), highlights Egypt’s untapped potential and explains the challenges currently being overcome in Egypt’s pharmaceutical sector. What makes Egypt the ‘go to’ market in…
Pharma Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare system. He also describes AbbVie’s role in this industry collective, and also depicts the company’s developing foothold within the South…
Pharma The President of Innothera talks about their unique business model, being in both the drug production and compression stockings businesses, how almost 95 percent of their drug production is exported, primarily to emerging countries, and why there is a very hopeful future for medium-sized companies that are ready to embrace…
See our Cookie Privacy Policy Here